Search: WFRF:(Berruti Alfredo) >
Temozolomide in Adv...
Temozolomide in Advanced Neuroendocrine Neoplasms : Pharmacological and Clinical Aspects
-
- Koumarianou, Anna (author)
- Attikon Univ Hosp, Hematol Oncol Unit, Dept Internal Med 4, GR-12462 Athens, Greece.
-
- Kaltsas, Gregory (author)
- Natl Tech Univ Athens, Dept Pathophysiol, Endocrine Unit, Athens, Greece.
-
- Kulke, Matthew H. (author)
- Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.
-
show more...
-
- Öberg, Kjell (author)
- Uppsala universitet,Endokrin Onkologi
-
- Strosberg, Jonathan R. (author)
- Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA.
-
- Spada, Francesca (author)
- European Inst Oncol, Gastrointestinal Med Oncol & Neuroendocrine Tumor, IT-20141 Milan, Italy.
-
- Galdy, Salvatore (author)
- European Inst Oncol, Gastrointestinal Med Oncol & Neuroendocrine Tumor, IT-20141 Milan, Italy.
-
- Barberis, Massimo (author)
- European Inst Oncol, Div Pathol, IT-20141 Milan, Italy.
-
- Fumagalli, Caterina (author)
- European Inst Oncol, Div Pathol, IT-20141 Milan, Italy.
-
- Berruti, Alfredo (author)
- Univ Brescia, Dipartimento Specialita Med Chirurg Sci Radiol &, Azienda Osped Spedali Civili, Brescia, Italy.
-
- Fazio, Nicola (author)
- European Inst Oncol, Gastrointestinal Med Oncol & Neuroendocrine Tumor, IT-20141 Milan, Italy.
-
show less...
-
Attikon Univ Hosp, Hematol Oncol Unit, Dept Internal Med 4, GR-12462 Athens, Greece Natl Tech Univ Athens, Dept Pathophysiol, Endocrine Unit, Athens, Greece. (creator_code:org_t)
- 2015-04-29
- 2015
- English.
-
In: Neuroendocrinology. - : S. Karger AG. - 0028-3835 .- 1423-0194. ; 101:4, s. 274-288
- Related links:
-
https://www.karger.c...
-
show more...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
show less...
Abstract
Subject headings
Close
- Alkylating agents, such as streptozocin and dacarbazine, have been reported as active in neuroendocrine neoplasms (NENs). Temozolomide (TMZ) is an oral, potentially less toxic derivative of dacarbazine, which has shown activity both as a single agent and in combination with other drugs. Nevertheless, its role in NENs has not been well defined. Several retrospective and prospective phase I-II studies have been published describing its use in a variety of NENs. In a retrospective series, the combination of capecitabine and TMZ was reported to be associated with a particularly high tumour response in pancreatic NENs as a first-line treatment. Although in NENs, determination of the CP-nnethylguanineDNA methyltransferase (MGMT) status has been suggested as a predictive biomarker of response, its role still remains investigational, awaiting validation along with the establishment of the optimal detection method. Metronomic schedules have been reported to potentially overcome MGMT-related drug resistance. Toxicity is manageable if well monitored. We reviewed the literature regarding pharmacological and clinical aspects of TMZ, focusing on specific settings of NENs, different schedules, toxicity and safety profiles, and potential predictive biomarkers of response.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Keyword
- Neuroendocrine neoplasms
- Pancreatic neuroendocrine neoplasms
- Neuroendocrine carcinomas
- Ki-67 labelling index
- Progression-free survival
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database
- By the author/editor
-
Koumarianou, Ann ...
-
Kaltsas, Gregory
-
Kulke, Matthew H ...
-
Öberg, Kjell
-
Strosberg, Jonat ...
-
Spada, Francesca
-
show more...
-
Galdy, Salvatore
-
Barberis, Massim ...
-
Fumagalli, Cater ...
-
Berruti, Alfredo
-
Fazio, Nicola
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Cancer and Oncol ...
- Articles in the publication
-
Neuroendocrinolo ...
- By the university
-
Uppsala University